Insider · CIK 0002058197

Apuli Maricel

Reports to the SEC for 1 company · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0002058197

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-16	BBIOBridgeBio Pharma, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−4,714 sh	$79.86	−$376K	122,687
2026-07-30	BBIOBridgeBio Pharma, Inc.S Sale	Chief Accounting Officer	SSale	−2,000 sh	$80.06	−$160K	127,401
2026-05-16	BBIOBridgeBio Pharma, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−4,714 sh	$66.13	−$312K	129,401
2026-04-30	BBIOBridgeBio Pharma, Inc.S Sale	Chief Accounting Officer	SSale	−2,000 sh	$71.58	−$143K	134,115
2026-03-18	BBIOBridgeBio Pharma, Inc.A Award	Chief Accounting Officer	AAward	+14.2K sh	—	—	136,115
2026-02-26	BBIOBridgeBio Pharma, Inc.S Sale	Chief Accounting Officer	SSale	−2,000 sh	$66.00	−$132K	121,945
2026-02-17	BBIOBridgeBio Pharma, Inc.S Sale	Chief Accounting Officer	SSale	−510 sh	$74.31	−$37.9K	123,945
2026-02-16	BBIOBridgeBio Pharma, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−4,349 sh	$75.25	−$327K	124,455
2025-12-12	BBIOBridgeBio Pharma, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−2,003 sh	$75.15	−$151K	128,294
2025-12-08	BBIOBridgeBio Pharma, Inc.S Sale	Chief Accounting Officer	SSale	−2,000 sh	$74.26	−$149K	130,297
2025-11-16	BBIOBridgeBio Pharma, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−4,781 sh	$66.39	−$317K	132,297
2025-08-16	BBIOBridgeBio Pharma, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−4,781 sh	$51.32	−$245K	137,078
2025-08-07	BBIOBridgeBio Pharma, Inc.S Sale	Chief Accounting Officer	SSale	−1,000 sh	$45.44	−$45.4K	141,859
2025-05-16	BBIOBridgeBio Pharma, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−4,780 sh	$33.84	−$162K	142,859
2025-05-02	BBIOBridgeBio Pharma, Inc.S Sale	Chief Accounting Officer	SSale	−1,026 sh	$38.51	−$39.5K	147,639
2025-03-19	BBIOBridgeBio Pharma, Inc.A Award	Chief Accounting Officer	AAward	+23.7K sh	—	—	148,665

Recent filings

Accepted (ET)
Aug 184
Apuli Maricel0001470831-26-000835
SEC(opens sec.gov)
Aug 34
Apuli Maricel0001470831-26-000745
SEC(opens sec.gov)
May 194
Apuli Maricel0001470831-26-000471
SEC(opens sec.gov)
May 44
Apuli Maricel0001470831-26-000410
SEC(opens sec.gov)
Mar 204
Apuli Maricel0001470831-26-000302
SEC(opens sec.gov)
Feb 274
Apuli Maricel0001470831-26-000225
SEC(opens sec.gov)
Feb 184
Apuli Maricel0001470831-26-000186
SEC(opens sec.gov)
Dec 164
Apuli Maricel0001470831-25-000418
SEC(opens sec.gov)
Dec 104
Apuli Maricel0001470831-25-000392
SEC(opens sec.gov)
Nov 184
Apuli Maricel0001470831-25-000349
SEC(opens sec.gov)
Aug 194
Apuli Maricel0000950170-25-110276
SEC(opens sec.gov)
Aug 114
Apuli Maricel0000950170-25-106751
SEC(opens sec.gov)
May 204
Apuli Maricel0000950170-25-075340
SEC(opens sec.gov)
May 64
Apuli Maricel0000950170-25-064567
SEC(opens sec.gov)
Mar 214
Apuli Maricel0000950170-25-043376
SEC(opens sec.gov)

Companies

BridgeBio Pharma, Inc.Chief Accounting OfficerBBIO

Address

C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250

PALO ALTO, CA, 94304